News

All news

2020-09-22

Paul Tredwell, Vice President Speciality Brands at Accord Healthcare talks to the Times

"We have revolutionised outcomes for patients, but healthcare spending is increasing which is a tough challenge. We have to balance the best patient outcomes with access to affordable, high-quality medicines, which is where companies like Accord come in"

Paul Tredwell, Vice President Speciality Brands at Accord Healthcare talks to the Times as part of their second Raconteur supplement on the 'Future of Healthcare'. In this special feature, Paul highlights that a new breed of generics company is emerging that are more patient-centric than their predecessors. Companies like Accord are not only providing more accessible solutions for complex biological medicines, but are also innovating with the aim to improve the patient experience of how those medicines are delivered.

You can read the full interview here

All news